Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy
- 20 April 2010
- journal article
- research article
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 29 (6) , 616-624
- https://doi.org/10.1016/j.healun.2010.02.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Advanced Heart Failure Treated with Continuous-Flow Left Ventricular Assist DeviceNew England Journal of Medicine, 2009
- Low Thromboembolism and Pump Thrombosis With the HeartMate II Left Ventricular Assist Device: Analysis of Outpatient Anti-coagulationThe Journal of Heart and Lung Transplantation, 2009
- European results with a continuous-flow ventricular assist device for advanced heart-failure patients☆European Journal of Cardio-Thoracic Surgery, 2009
- Extended Mechanical Circulatory Support With a Continuous-Flow Rotary Left Ventricular Assist DevicePublished by Elsevier ,2009
- Low thromboembolic risk for patients with the Heartmate II left ventricular assist deviceThe Journal of Thoracic and Cardiovascular Surgery, 2008
- HeartMate II left ventricular assist device; early European experienceEuropean Journal of Cardio-Thoracic Surgery, 2008
- Use of a Continuous-Flow Device in Patients Awaiting Heart TransplantationNew England Journal of Medicine, 2007
- Multicenter clinical evaluation of the HeartMate vented electric left ventricular assist system in patients awaiting heart transplantationThe Journal of Thoracic and Cardiovascular Surgery, 2001
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- HeartMate II left ventricular assist system: from concept to first clinical useThe Annals of Thoracic Surgery, 2001